&w=3840&q=100)
Sun Pharma partner Philogen withdraws EU application for skin cancer drug
Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback
Anjali Singh Mumbai
Listen to This Article
Sun Pharmaceutical's European partner Philogen S.p.A has voluntarily withdrawn its marketing authorisation application for its investigational skin cancer therapy Nidlegy in the European Union (EU). The decision comes a year after the application was submitted to the European Medicines Agency (EMA) for the treatment of locally advanced, fully resectable melanoma.
Analysts believe while this development may not have any immediate financial repercussions for Sun Pharma, it could influence the company's long-term strategic positioning, particularly in the European and Australian markets.
'The timing of this development is also unfavourable for the company, considering the setback earlier this month when another investigational
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
31 minutes ago
- Time of India
China's top diplomat visits Europe pitching closer ties in 'volatile' world
China's top diplomat visits Europe pitching closer ties in 'volatile' world (Image: AP) BEIJING: China's top diplomat heads to Europe on Monday for a visit which Beijing said will highlight ties as an "anchor of stability" in a world in turmoil. Wang Yi's tour will take him to the European Union's headquarters in Brussels as well as France and Germany as China seeks to improve relations with the bloc as a counterweight to superpower rival the United States. But deep frictions remain over the economy- including a yawning trade deficit of $357.1 billion between China and the EU- and Beijing's close ties with Russia despite Moscow's war in Ukraine. "The world is undergoing an accelerated evolution of a century-old change, with unilateralism, protectionism and bullying behaviour becoming rampant," Chinese foreign ministry spokesman Guo Jiakun said on Friday -- a thinly veiled swipe against the United States under President Donald Trump. In that context, Guo said, Beijing and the European bloc must "keep the world peaceful and stable, safeguard multilateralism, free trade, international rules, fairness and justice, and act firmly as anchors of stability and constructive forces in a volatile world". Wang will meet with his EU counterpart, Kaja Kallas, at the bloc's headquarters in Brussels for "high-level strategic dialogue". In Germany, he will hold talks with Foreign Minister Johann Wadephul on diplomacy and security -- his first visit since Berlin's new conservative-led government took power in May. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Perdagangkan CFD Emas dengan Broker Tepercaya IC Markets Mendaftar Undo And in France, Wang will meet minister for Europe and foreign affairs Jean-Noel Barrot, who visited China in March. The war in Ukraine will likely be high on the agenda, with European leaders having been forthright in condemning what they say is Beijing's backing for Moscow. China has portrayed itself as a neutral party in Russia's more than three-year war with Ukraine. But Western governments say Beijing's close ties have given Moscow crucial economic and diplomatic support, and they have urged China to do more to press Russia to end the war. Trade tensions Ties between Europe and China have also strained in recent years as the EU seeks to get tougher on what it says are unfair economic practices by Beijing. After the European bloc placed tariffs on Chinese electric vehicle imports, China retaliated with its own duties, including on French cognac. An agreement on cognac has been reached with Beijing but not formally approved by the Chinese commerce ministry, a source in the French economy ministry told AFP. The source said finalization was partially linked with the EU's ongoing negotiations over EVs. Tensions flared this month after the EU banned Chinese firms from government medical device purchases worth more than five million euros ($5.8 million), in retaliation for limits Beijing places on access to its own market. The latest salvo in trade tensions between the 27-nation bloc and China covered a wide range of healthcare supplies, from surgical masks to X-ray machines, that represent a market worth 150 billion euros in the EU. In response, China accused the European Union of "double standards". Another sticking point has been rare earths. Beijing has since April required licences to export these strategic materials from China, which accounts for almost two-thirds of rare earth mining production and 92 percent of global refined output, according to the International Energy Agency. The metals are used in a wide variety of products, including electric car batteries, and there has been criticism from industries about the way China's licences have been issued. China has proposed establishing a "green channel" to ease the export of rare earths to the EU, its commerce ministry said this month.
Mint
an hour ago
- Mint
Global Funds May Shift From Indian Stock Market to China on Improving Sentiment
Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at: Good morning, this is Chiranjivi Chakraborty, an equities reporter in Mumbai. Nifty futures point to a positive start this morning after stocks last week posted their biggest gain since mid-May. Strength in other Asian markets and recent technical breakouts should further boost sentiment. The focus this week will be on HDB Financial's listing and monthly automobile sales data. Strong response for HDB IPO to spur Tata Capital The strong demand for HDB Financial's $1.5 billion initial public offering may nudge Tata Capital Ltd.'s decision-makers into fast-tracking their offering once regulatory approval comes through. The market response to the HDB IPO also signals an appetite for reasonably priced papers at a time when local stocks trade at a near-record valuation. That's the other lesson for Tata Capital, which is poised to be the year's largest IPO: leave something on the table for investors. Near term challenges seen for cement stocks Elara expects cement firms to face monsoon-related weakness, affecting demand and pricing. Also, continued capacity addition is expected to keep utilization levels within a range. However, demand could rebound this financial year, driven by improved execution of government initiatives for rural housing and irrigation, the analysts note. Profitability of local non-ferrous companies can improve: JM JM Financial analysts see steady crude derivatives, weaker caustic soda prices, and stable thermal coal costs aiding the profitability of domestic non-ferrous companies. In particular, aluminum prices are expected to be supported by the 45 metric tonnes per annum cap on Chinese aluminum capacity, higher European defense outlay, and lower LME inventory levels, they note. JM's preferred picks are Hindalco and Nalco. Three great reads from Bloomberg today: The euphoria surrounding India's $5.3 trillion equity market is cooling as earnings growth slows and the government cuts back on infrastructure investment. To make matters worse, improving sentiment toward Hong Kong-listed Chinese shares is threatening to lure global funds away and prolong the underperformance of Indian shares versus their Asian peers. To read India Markets Buzz every day, follow Bloomberg India on WhatsApp. . This article was generated from an automated news agency feed without modifications to text.
Mint
2 hours ago
- Mint
Star Entertainments Queens Wharf stake exit deal collapses
(Adds shares in paragraph 4, background in paragraphs 5-8, additional details in paragraph 10) June 30 (Reuters) - Australia's Star Entertainment said it had received a notice from Hong Kong's Far East Consortium International and Chow Tai Fook Enterprises to terminate the deal to sell its 50% stake in its Queen's Wharf project in Brisbane. The termination is set to take effect five business days from June 30, unless withdrawn earlier. The March 7 agreement outlined the casino operator's planned exit from its equity interest in Destination Brisbane Consortium (DBC), but the parties had not resolved outstanding key commercial issues of the deal as of this morning, Star said in a statement on Monday. Shares of Star were, however, up 1.7% at A$0.147, as of 0104 GMT. The casino and hotel complex was developed for A$3.6 billion ($2.35 billion), Star's website says. For years, Star and Blackstone-owned larger rival Crown Resorts have faced multiple inquiries into anti-money laundering rule violations and subsequent legal actions. Had the deal gone through, Far East Consortium and Chow Tai Fook Enterprises were set to become the sole owner of the Brisbane venture, which has luxury hotels and restaurants and other amenities. Star was, in turn, set to take on the investors' 66.67% stake in a Gold Coast project in Queensland. In a separate statement, property developer Far East Consortium said that Star must repay A$10 million within 30 days of termination, failing which it must transfer its 33.3% stake in Tower 1 (Dorsett) to the Hong Kong parties. "Despite the receipt of this notice, The Star remains willing to continue negotiations with the Joint Venture Partners to give effect to the DBC transaction," Star added. Star Entertainment did not immediately respond to a Reuters email seeking confirmation of the repayment details. ($1 = 1.5314 Australian dollars) (Reporting by Shivangi Lahiri in Bengaluru; Editing by Rashmi Aich)
